021-51111890
购物车（0）
sales@molnova.cn
Izonsteride
CAS No. 176975-26-1
Izonsteride ( —— )
产品货号. M34293 CAS No. 176975-26-1
Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.Izonsteride is used in the treatment of oncology and genitourinary disorders, and may be used in the study of prostate cancer.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2067 | 有现货 |
|
| 5MG | ￥3230 | 有现货 |
|
| 10MG | ￥4845 | 有现货 |
|
| 25MG | ￥7499 | 有现货 |
|
| 50MG | ￥10010 | 有现货 |
|
| 100MG | ￥13388 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Izonsteride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.Izonsteride is used in the treatment of oncology and genitourinary disorders, and may be used in the study of prostate cancer.
-
产品描述Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.Izonsteride is used in the treatment of oncology and genitourinary disorders, and may be used in the study of prostate cancer.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Reductase
-
受体Reductase
-
研究领域——
-
适应症——
化学信息
-
CAS Number176975-26-1
-
分子量422.61
-
分子式C24H26N2OS2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC[C@@]12C=3C(=CC(SC4=NC=5C(S4)=CC=CC5CC)=CC3)CC[C@]1(N(C)C(=O)CC2)[H]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
WJ-39
WJ-39 is an orally active aldose reductase (AR) inhibitor that ameliorates renal lesions in diabetic nephropathy through activation of Nrf2 signaling, and may be used to ameliorate renal insufficiency and fibrosis.WJ-39 inhibits oxidative stress and inhibits the activation of the inflammatory vesicle of the oligomerization structural domain-like receptor family, pyrin structural domain 3 (NLRP3).
-
Minalrestat
Minalrestat (ARI-509) 是一种有效的具有口服活性的醛糖还原酶 (aldose reductase) 抑制剂。Minalrestat 可用于糖尿病的研究。
-
Ponalrestat
ponalrestat 是一种醛糖还原酶抑制剂，可激活脂肪组织中的脂蛋白脂肪酶 (LPL) 活性，并减轻小鼠 B16 黑色素瘤引起的恶病质症状
